Dynarb 150 mg, 300 mg Tablet.
PDF Leaflet Revision Date: 09 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of essential hypertension and diabetic nephropathy in type 2 diabetes.
Dosage (summary)
150 mg once daily, may increase to 300 mg if needed.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Fluoroquinolones
- Lithium
- Potassium-sparing diuretics
- NSAIDs
Contraindications
- Hypersensitivity to irbesartan
- History of angioedema
- Severe renal impairment
- Severe hepatic impairment
- Bilateral renal artery stenosis
Common side effects
- Dizziness
- Headache
- Fatigue
- Hyperkalaemia
Counselling Points
- Take with or without food
- Monitor blood pressure regularly
- Avoid potassium supplements
Serious warnings
- Risk of hypotension in volume-depleted patients
- Potential for renal impairment
Important Disclaimer
The Dynarb 150 mg, 300 mg Tablet. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
